Alphamab Oncology
HKEX:9966.HK
3.87 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 1,140.194 | 1,085.988 | 1,136.302 | 1,069.189 | 977.367 | 803.306 | 702.018 | 185.321 | 240.193 | 1,867.866 | 253.562 | 633.712 |
| Short Term Investments
| 316.392 | 321.248 | 445.29 | 247.858 | 637.541 | 1,128.168 | 1,159.836 | 1,835.398 | 2,217.426 | 514.569 | 655.431 | 0 |
| Cash and Short Term Investments
| 1,456.586 | 1,407.236 | 1,581.592 | 1,350.377 | 1,708.918 | 1,985.484 | 1,916.864 | 2,064.249 | 2,477.699 | 2,382.435 | 908.993 | 633.712 |
| Net Receivables
| 13.166 | 7.131 | 23.555 | 15.49 | 14.84 | 7.606 | -55.01 | -43.53 | -20.08 | -11.68 | -1.68 | 0 |
| Inventory
| 65.163 | 78.747 | 62.933 | 64.636 | 75.62 | 57.908 | 51.002 | 44.321 | 32.992 | 25.918 | 20.506 | 7.068 |
| Other Current Assets
| 57.917 | 65.416 | 54.657 | 97.357 | 162.446 | 119.561 | 111.853 | 134.188 | 76.26 | 36.115 | 33.492 | 15.323 |
| Total Current Assets
| 1,592.832 | 1,558.53 | 1,722.737 | 1,494.53 | 1,867.814 | 2,116.549 | 2,024.709 | 2,199.228 | 2,566.871 | 2,444.468 | 962.991 | 656.103 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 547.034 | 556.841 | 604.676 | 619.743 | 576.161 | 530.523 | 416.796 | 393.021 | 380.357 | 355.956 | 235.301 | 135.091 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 20.691 | 0 | 21.185 | 0 | 21.68 | 0 | 22.175 | 0 | 22.669 | 24.73 | 24.73 |
| Goodwill and Intangible Assets
| 0 | 20.691 | 0 | 21.185 | 0 | 21.68 | 0 | 22.175 | 0 | 22.669 | 24.73 | 24.73 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.136 | 1.051 | -604.676 | -21.185 | -576.161 | -21.68 | -416.796 | -22.175 | -380.357 | 31.49 | 27.019 | 10.969 |
| Total Non-Current Assets
| 549.17 | 578.583 | 604.676 | 619.743 | 576.161 | 530.523 | 416.796 | 393.021 | 380.357 | 410.115 | 287.05 | 170.79 |
| Total Assets
| 2,142.002 | 2,137.113 | 2,328.389 | 2,117.531 | 2,461.697 | 2,705.091 | 2,500.155 | 2,639.522 | 2,980.082 | 2,854.583 | 1,250.041 | 826.893 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 23.658 | 27.163 | 19.414 | 12.127 | 17.634 | 28.481 | 16.267 | 5.277 | 14.29 | 6.853 | 9.364 | 0.766 |
| Short Term Debt
| 170 | 80.498 | 81.238 | 190.113 | 339.102 | 463.814 | 221.154 | 198.146 | 67.865 | 41.831 | 10.718 | 10.502 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 122.737 | -1.119 | -81.238 | -190.113 | -339.102 | -463.814 | -221.154 | -198.146 | -67.865 | 0 | 0 | 0 |
| Other Current Liabilities
| 28.981 | 160.296 | 241.882 | 372.785 | 506.278 | 608.779 | 366.758 | 324.258 | 187.302 | 151.846 | 78.991 | 71.532 |
| Total Current Liabilities
| 345.376 | 266.838 | 261.296 | 384.912 | 523.912 | 637.26 | 383.025 | 329.535 | 201.592 | 200.53 | 99.073 | 82.8 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 150 | 176.582 | 200 | 150 | 173.733 | 153.826 | 86.712 | 21.35 | 172.5 | 211.345 | 165.659 | 100.518 |
| Deferred Revenue Non-Current
| 0 | 21.581 | 17.924 | 19.668 | 22.358 | 24.086 | 14.51 | 12.244 | 12.244 | 16.783 | 10 | 10 |
| Deferred Tax Liabilities Non-Current
| 0 | -21.581 | 182.076 | 130.332 | 151.375 | 129.74 | 72.202 | 9.106 | 160.256 | 201.25 | -155.577 | -99.25 |
| Other Non-Current Liabilities
| 17.875 | 21.581 | -200 | -150 | -173.733 | -153.826 | -86.712 | -21.35 | -172.5 | -201.25 | 1,444.158 | 999.853 |
| Total Non-Current Liabilities
| 167.875 | 198.163 | 200 | 150 | 173.733 | 153.826 | 86.712 | 21.35 | 172.5 | 228.128 | 1,464.24 | 1,011.121 |
| Total Liabilities
| 513.251 | 465.001 | 481.569 | 559.859 | 733.265 | 834.802 | 489.573 | 366.438 | 395.632 | 428.658 | 1,563.313 | 1,093.921 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 34.429 | 35.853 | 39.752 | 39.841 | 44.495 | 45.454 | 53.263 | 966.458 | 193.504 | 147.373 |
| Common Stock
| 0.013 | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 | 0.012 | 0.007 | 0.007 |
| Retained Earnings
| 0 | -2,342.956 | -2,172.225 | -2,132.363 | -1,953.95 | -1,806.641 | -1,661.588 | -1,394.224 | -1,069.558 | -966.458 | -193.504 | -147.373 |
| Accumulated Other Comprehensive Income/Loss
| 1,628.738 | 1,672.099 | -34.429 | -35.853 | -39.752 | -39.841 | -44.495 | -45.454 | -53.263 | -2.201 | -13.511 | -8.235 |
| Other Total Stockholders Equity
| 0 | 2,342.956 | 4,019.032 | 3,690.022 | 3,682.369 | 3,676.917 | 3,672.157 | 3,667.295 | 3,653.995 | 2,428.114 | -299.768 | -258.8 |
| Total Shareholders Equity
| 1,628.751 | 1,672.112 | 1,846.82 | 1,557.672 | 1,728.432 | 1,870.289 | 2,010.582 | 2,273.084 | 2,584.45 | 2,425.925 | -313.272 | -267.028 |
| Total Equity
| 1,628.751 | 1,672.112 | 1,846.82 | 1,557.672 | 1,728.432 | 1,870.289 | 2,010.582 | 2,273.084 | 2,584.45 | 2,425.925 | -313.272 | -267.028 |
| Total Liabilities & Shareholders Equity
| 2,142.002 | 2,137.113 | 2,328.389 | 2,117.531 | 2,461.697 | 2,705.091 | 2,500.155 | 2,639.522 | 2,980.082 | 2,854.583 | 1,250.041 | 826.893 |